Clinical Trial Applications: Filter, Search, and view applications
# | Protocol No | Study Title | Investigator(s) & Site(s) | |
---|---|---|---|---|
406. |
ECCT/23/06/08 | TSCV3000 Age-descending, randomized, placebo-controlled Phase 2 trial in three sites in sub-Saharan Africa to assess the safety and immunogenicity of a parenteral Trivalent … read more |
Principal Investigator(s) 1. RICHARD ONYANDO OMORE Site(s) in Kenya 1. SIAYA COUNTY REFERRAL HOSPITAL (Siaya county) 2. ST. ELIZABETH LWAK HOSPITAL (Siaya county) |
View |
407. |
ECCT/23/06/09 |
Hibiscus Kid\'s Study A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients with Sickle Cell Disease |
Principal Investigator(s) 1. Walter Otieno 2. Videlis Nduba Site(s) in Kenya 1. Kombewa Clinical research Centre (Kisumu county) 2. KEMRI, Siaya Clinical… read more |
View |
408. |
ECCT/23/07/01 | POWWeR Health Study Single arm trial of menstrual cups among economically vulnerable women to reduce Bacterial vaginosis and STIs through reduced harmful sexual and menstrual… read more |
Principal Investigator(s) 1. Fredrick Otieno 2. Supriya Dinesh Mehta Site(s) in Kenya Nyanza Reproductive Health Society |
View |
409. |
ECCT/23/07/03 |
ARNASA A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
Principal Investigator(s) 1. Professor Videlis Nduba 2. Professor Videlis Nduba Site(s) in Kenya 1. KENYA MEDICAL RESEARCH INSTITUTE-CENTRE FOR RESPIRATORY… read more |
View |
410. |
ECCT/23/07/04 |
PRAISE An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease (PRAISE) |
Principal Investigator(s) 1. Dr. Janet Oyieko Site(s) in Kenya 1. Kondele Children\'s Hospital Center for Clinical Research (CCR), (Kisumu county) 2.… read more |
View |